PLAINSBORO, N.J., Dec. 18 /PRNewswire/ -- RHEI Pharmaceuticals, Inc. today announced that it has received approval from the State Food and Drug Administration (SFDA) in China for the marketing of its first product, the Drs. Hans Schreuder Scar Treatment product, as well as three companion products that are part of the Drs. Hans Schreuder Vision for Health Skin Care line. This product, currently marketed in a number of countries, has received very positive comments from consumers in Europe for helping to restore post traumatic skin back to normal.
Advertisement
"We are very pleased with this first approval of a RHEI product in China. We licensed the Drs. Hans Schreuder natural skin care line in February of this year and this approval underscores RHEI's capability to bring products through the Chinese development and regulatory system in an efficient manner," said Dr. Geert Cauwenbergh, Chief Executive Officer and Chairman of RHEI Pharmaceuticals. "We are particularly excited to commercialize this product in Asia, as the benefits and the market opportunity of providing consumers and patients, who have suffered skin trauma, with an ability to have their skin restored to normal is very substantial."
Advertisement
RHEI Pharmaceuticals will guide the marketing message and marketing support for the product, and is currently negotiating a sales and distribution agreement for hospital and pharmacy detailing with one of the premier distributors of health care products in China.
About Drs. Hans Schreuder Scar Treatment
Drs. Hans Schreuder Vision for Health Skin Care line contains skin-inherent substances like natural vitamin E and nutritional ingredients from nature itself, such as oatmeal, yeast and hamamelis extracts, soya, rice, natural vitamins and natural lactic acid. These ingredients can solve problems and restore the skin's natural balance. The Scar Treatment product contacts soya extract, which is known to even out skin tone and texture. The cream also contains natural vitamin E, natural lactic acid, and rice and camomile extracts. These nutrients reduce scars while nourishing and moisturizing the skin.
About RHEI Pharmaceuticals
RHEI Pharmaceuticals is a venture backed specialty pharmaceutical company with operations in Belgium, the U.S. and in China that acquires, licenses, develops and commercializes in China proprietary drug therapies based upon the unmet needs of the emerging China pharmaceuticals market. The Company leverages its proprietary and extensive network of experienced clinical development and regulatory professionals in China to expedite approvals for pharmaceuticals new to the China market. RHEI's growing sales and marketing capabilities then provide broad patient access in China to these new and critically necessary therapeutics. RHEI applies its unique offering to branded pharmaceuticals, through its Ethical Division, and to consumer healthcare and OTC/natural supplement products through its Pharmacy Division. Additional information can be found at www.rheipharma.com.
SOURCE RHEI Pharmaceuticals, Inc.
